Literature DB >> 12018673

Fatal acute myocardial infarction during severe thrombocytopenia in a patient with idiopathic thrombocytopenic purpura.

Oren Fruchter1, Miry Blich, Giris Jacob.   

Abstract

Because platelets play a major role in most thrombotic events, it is not surprising that all cases of myocardial infarctions in patients with idiopathic thrombocytopenic purpura (ITP) have been reported to occur only when platelets counts begin to rise. We report on a 69-year-old man with ITP who had acute myocardial infarction while he was severely thrombocytopenic (2000/microL). We hypothesize that the pathogenesis of myocardial infarction in thrombocytopenic patients with ITP may result from endothelial damage induced by autoantibodies directed against antigens present on both platelets and coronary endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12018673     DOI: 10.1097/00000441-200205000-00010

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  10 in total

1.  Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia--a case report.

Authors:  Tomohide Hayashi; Naoki Akioka; Daina Kashiwazaki; Naoya Kuwayama; Satoshi Kuroda
Journal:  Childs Nerv Syst       Date:  2015-02-08       Impact factor: 1.475

2.  Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.

Authors:  Merav Lidar; Sewar Masarwa; Pnina Rotman; Or Carmi; Noa Rabinowicz; Yair Levy
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

3.  Acute ST Elevation Myocardial Infarction in Patients With Immune Thrombocytopenia Purpura: A Case Report.

Authors:  Sandeep K Dhillon; Edwin Lee; John Fox; Maurice Rachko
Journal:  Cardiol Res       Date:  2011-01-20

4.  Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia.

Authors:  Syed Wamique Yusuf; Cezar Iliescu; Jaya D Bathina; Iyad N Daher; Jean-Bernard Durand
Journal:  Tex Heart Inst J       Date:  2010

5.  Primary percutaneous coronary intervention for acute myocardial infarction with idiopathic thrombocytopenic purpura: a case report.

Authors:  Jun Hyung Kim; Keon Uk Park; Woo Jung Chun; Seong Ho Kim; Deuk Young Nah
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

6.  Primary percutaneous coronary intervention for acute myocardial infarction in a young female with idiopathic thrombocytopenic purpura: a case report and review.

Authors:  Ahmet Yildiz; Ugur Coskun; Ozlem Esen Batukan; Kudret Keskin
Journal:  Case Rep Med       Date:  2010-03-24

7.  Recurrent ischemic stroke in a patient with idiopathic thrombocytopenic purpura.

Authors:  Hak Young Rhee; Hye-Yeon Choi; Sang-Beom Kim; Won-Chul Shin
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

8.  Revascularization for patients with idiopathic thrombocytopenic purpura and coronary artery disease.

Authors:  Chan-Hee Lee; Ung Kim
Journal:  Korean Circ J       Date:  2014-07-25       Impact factor: 3.243

9.  Multivessel coronary thrombosis in a patient with idiopathic thrombocytopenic purpura.

Authors:  Julide Yagmur; Mehmet Cansel; Nusret Acikgoz; Murat Yagmur; Ferhat Eyupkoca; Necip Ermis; Erdal Akturk
Journal:  Tex Heart Inst J       Date:  2012

10.  Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura.

Authors:  Sena Sert; Hasan Özdil; Murat Sünbül
Journal:  Turk J Haematol       Date:  2016-12-12       Impact factor: 1.831

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.